시장보고서
상품코드
1760511

세계의 피임약 및 피임기구 시장 보고서(2025년)

Contraceptive Drugs And Devices Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

피임약 및 피임기구 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 7.5%의 연평균 성장률(CAGR)을 기록하여 363억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 장기 지속형 가역 피임약에 대한 수요 증가, 여성의 생식 건강에 대한 관심 증가, 성병 유병률 증가, E-Commerce 및 원격의료를 통한 접근성 확대, 의료 정책 및 보험 적용 지원 등의 요인에 기인하는 것으로 분석됩니다. 예측 기간의 주요 동향으로는 디지털 추적 기능을 갖춘 스마트 피임약 개발, 생분해성 임플란트 및 패치, 호르몬이 없는 피임약의 혁신, AI를 활용한 불임 치료 모니터링 앱, 맞춤형 피임약의 3D 프린팅 등을 꼽을 수 있습니다.

생식 건강에 초점을 맞춘 정부 이니셔티브의 증가는 피임약 및 피임기구 시장의 성장을 촉진할 것으로 예상됩니다. 이러한 이니셔티브는 인식 개선 캠페인, 자금 지원, 서비스 접근성을 통해 생식 건강을 증진하는 것을 목표로 하고 있습니다. 정부는 임산부 건강, 가족계획, 필수적인 의료 서비스에 대한 접근성 등의 문제를 해결하는 것이 사회 복지와 발전에 매우 중요하다는 것을 점점 더 많이 인식하고 있습니다. 피임약 및 피임기구에 대한 정부의 노력은 저렴하고 효과적인 가족계획에 대한 접근성을 높이고, 개인이 자신의 생식 건강에 대한 정보에 입각한 선택을 할 수 있도록 하는 것을 목표로 하고 있습니다. 예를 들어, 2024년 11월 호주 외교통상부는 동남아시아의 성 및 생식 건강 및 권리 증진을 위한 새로운 이니셔티브에 5,680만 달러를 배정할 것이라고 발표했습니다. 결과적으로, 생식 건강 관련 정부 이니셔티브의 증가는 피임약 및 피임기구 시장의 성장을 촉진하고 있습니다.

피임약 및 피임기구 시장의 주요 업체들은 피임용 질 링과 같은 혁신적인 제품 개발에 주력하여 편의성을 높이고 장기 지속형 피임 방법의 선택의 폭을 넓히고 있습니다. 피임용 질 링은 배란을 억제하고 임신을 방지하기 위해 질 내에 삽입하는 유연한 호르몬 방출 장치입니다. 예를 들어, 2023년 10월 미국 제약회사 시로메드(Xiromed LLC)는 에토노게스트렐(프로게스틴)과 에티닐에스트라디올(에스트로겐)의 조합을 3주 동안 방출하여 배란을 방지하도록 설계된 부드럽고 유연한 피임용 질 링인 에니요링(EnilloRing)을 출시했습니다. NuvaRing과 생물학적으로 동등한 제네릭 의약품인 EnilloRing은 매일 복용할 필요가 없고, 눈에 잘 띄지 않으며, 편리하고, 비용 효율적인 월경 피임 옵션을 여성에게 제공하면서 오리지널 의약품과 동등한 안전성, 유효성 및 내약성을 유지합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 피임약 및 피임기구 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
  • 최종 이용 산업 분석
  • 세계의 피임약 및 피임기구 시장 : 성장률 분석
  • 세계의 피임약 및 피임기구 시장 실적 : 규모와 성장, 2019-2024년
  • 세계의 피임약 및 피임기구 시장 예측 : 규모와 성장, 2024-2029년, 2034년
  • 세계의 피임약 및 피임기구 전체 시장(TAM)

제6장 시장 세분화

  • 세계의 피임약 및 피임기구 시장 : 제품별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
  • 피임약
  • 피임기구
  • 세계의 피임약 및 피임기구 시장 : 기술별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
  • 기존 피임 방법
  • 디지털 피임 앱
  • 웨어러블 디바이스
  • 장기 작용형 가역적 피임약(LARC)
  • 세계의 피임약 및 피임기구 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
  • 병원 약국
  • 소매 약국
  • 클리닉
  • 온라인 채널
  • 공공 채널·비정부 조직
  • 기타
  • 세계의 피임약 및 피임기구 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
  • 남성
  • 여성
  • 세계의 피임약 및 피임기구 시장 : 피임약 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
  • 경구 피임약
  • 주사 피임약
  • 피임 패치
  • 질 링
  • 응급 피임약
  • 호르몬 임플란트
  • 세계의 피임약 및 피임기구 시장 : 피임기구 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
  • 남성용 콘돔
  • 여성용 콘돔
  • 자궁내 피임기구(IUD)
  • 자궁경관 캡·자궁내막 캡
  • 피임 스펀지
  • 멸균 장비

제7장 지역별·국가별 분석

  • 세계의 피임약 및 피임기구 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
  • 세계의 피임약 및 피임기구 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 피임약 및 피임기구 시장 : 경쟁 구도
  • 피임약 및 피임기구 시장 : 기업 개요
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

  • Teva Pharmaceuticals Ltd
  • Lupin Limited
  • CooperSurgical Inc.
  • Mithra Pharmaceuticals
  • DKT International
  • Fuji Latex Co Ltd
  • Agile Therapeutics Inc.
  • Cupid Limited
  • Veru Inc.
  • Eskag Pharma Pvt. Ltd.
  • Biosante Pharmaceuticals Inc.
  • HLL Lifecare Limited
  • Afaxys Inc.
  • The Female Health Company(FC2)
  • Mayer Laboratories Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

  • 피임약 및 피임기구 시장 2029년 : 새로운 기회를 제공하는 국가
  • 피임약 및 피임기구 시장 2029년 : 새로운 기회를 제공하는 부문
  • 피임약 및 피임기구 시장 2029년 : 성장 전략
    • 시장 동향에 기반한 전략
    • 경쟁 전략

제36장 부록

ksm 25.07.08

Contraceptive drugs and devices are medical products designed to prevent pregnancy using various methods. Contraceptive drugs typically contain synthetic hormones that inhibit ovulation, thicken cervical mucus, or alter the uterine lining. On the other hand, contraceptive devices include physical barriers that block sperm from reaching the egg and systems inserted into the uterus to prevent fertilization or implantation.

The primary categories of contraceptive products are contraceptive drugs and contraceptive devices. Contraceptive drugs are medications that work by disrupting the normal processes of ovulation, fertilization, or implantation. The technologies involved range from traditional methods and digital contraceptive apps to wearable devices and long-acting reversible contraceptives (LARCs). These products are distributed through various channels such as hospital pharmacies, retail pharmacies, clinics, online platforms, public channels, and non-governmental organizations, serving a diverse range of end users, including both males and females.

The contraceptive drugs and devices market research report is one of a series of new reports from The Business Research Company that provides contraceptive drugs and devices market statistics, including contraceptive drugs and devices industry global market size, regional shares, competitors with a contraceptive drugs and devices market share, detailed contraceptive drugs and devices market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptive drugs and devices industry. The contraceptive drugs and devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The contraceptive drugs and devices market size has grown strongly in recent years. It will grow from$25.30 billion in 2024 to $27.24 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to factors such as population growth, heightened awareness of family planning, government initiatives and funding, a growing number of working women, and advancements in contraceptive technologies.

The contraceptive drugs and devices market size is expected to see strong growth in the next few years. It will grow to$36.31 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to factors such as the growing demand for long-acting reversible contraceptives, increasing focus on women's reproductive health, the rising prevalence of sexually transmitted infections, expanded access through e-commerce and telehealth, as well as supportive healthcare policies and insurance coverage. Major trends in the forecast period include the development of smart contraceptive devices with digital tracking, biodegradable implants and patches, innovations in hormone-free contraceptives, AI-driven fertility monitoring apps, and the 3D printing of custom-fit contraceptive devices.

The increasing number of government initiatives focused on reproductive health is expected to drive the growth of the contraceptive drugs and devices market. These initiatives aim to promote reproductive health through awareness campaigns, funding, and access to services. Governments are increasingly recognizing the importance of addressing issues such as maternal health, family planning, and access to essential healthcare services, all of which are crucial for societal well-being and development. Government efforts targeting contraceptive drugs and devices aim to increase access to affordable and effective family planning methods, enabling individuals to make informed choices about their reproductive health. For example, in November 2024, the Australian Government Department of Foreign Affairs and Trade announced an allocation of $56.8 million for a new initiative aimed at promoting sexual and reproductive health and rights in Southeast Asia. As a result, the rise in government initiatives related to reproductive health is boosting the growth of the contraceptive drugs and devices market.

Key players in the contraceptive drugs and devices market are focusing on developing innovative products, such as contraceptive vaginal rings, to enhance convenience and expand long-acting contraceptive options. A contraceptive vaginal ring is a flexible, hormone-releasing device inserted into the vagina to prevent pregnancy by inhibiting ovulation. For example, in October 2023, Xiromed LLC, a U.S.-based pharmaceutical company, introduced EnilloRing, a soft, flexible contraceptive vaginal ring designed to release a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, EnilloRing provides women with a discreet, convenient, and cost-effective monthly birth control option that eliminates the need for daily dosing, while maintaining the same safety, efficacy, and tolerability as the branded version.

In March 2024, Insud Pharma SL, a Spain-based pharmaceutical company, acquired Viatris Inc.'s women's healthcare business for an undisclosed amount. This acquisition strengthens Insud Pharma's presence in emerging markets by acquiring two manufacturing facilities in India, enhancing its ability to supply oral contraceptives to global public health institutions. Viatris Inc., a U.S.-based pharmaceutical and healthcare company, specializes in oral and injectable contraceptives.

Major players in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., and Dare Bioscience Inc.

North America was the largest region in the contraceptive drugs and devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in contraceptive drugs and devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the contraceptive drugs and devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The contraceptive drugs and devices market consists of sales of hormonal pills, emergency contraceptives, contraceptive implants, intrauterine devices (IUDs), condoms, patches, and vaginal rings. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contraceptive Drugs And Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contraceptive drugs and devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for contraceptive drugs and devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The contraceptive drugs and devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Contraceptive Drugs; Contraceptive Devices
  • 2) By Technology: Traditional Methods; Digital Contraceptive Apps; Wearable Devices; Long-Acting Reversible Contraceptives (LARCs)
  • 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channels; Public Channels And Non-Governmental Organizations; Other Distribution Channels
  • 4) By End User: Male; Female
  • Subsegments:
  • 1) By Contraceptive Drugs: Oral Contraceptive Pills; Injectable Contraceptives; Contraceptive Patches; Vaginal Rings; Emergency Contraceptive Pills; Hormonal Implants
  • 2) By Contraceptive Devices: Male Condoms; Female Condoms; Intrauterine Devices (IUDs); Diaphragms And Cervical Caps; Contraceptive Sponges; Sterilization Devices
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co Inc.; Bayer AG; Viatris Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Contraceptive Drugs And Devices Market Characteristics

3. Contraceptive Drugs And Devices Market Trends And Strategies

4. Contraceptive Drugs And Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Contraceptive Drugs And Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Contraceptive Drugs And Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Contraceptive Drugs And Devices Market Growth Rate Analysis
  • 5.4. Global Contraceptive Drugs And Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Contraceptive Drugs And Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Contraceptive Drugs And Devices Total Addressable Market (TAM)

6. Contraceptive Drugs And Devices Market Segmentation

  • 6.1. Global Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Contraceptive Drugs
  • Contraceptive Devices
  • 6.2. Global Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Methods
  • Digital Contraceptive Apps
  • Wearable Devices
  • Long-Acting Reversible Contraceptives (LARCs)
  • 6.3. Global Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channels
  • Public Channels And Non-Governmental Organizations
  • Other Distribution Channels
  • 6.4. Global Contraceptive Drugs And Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Male
  • Female
  • 6.5. Global Contraceptive Drugs And Devices Market, Sub-Segmentation Of Contraceptive Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Contraceptive Pills
  • Injectable Contraceptives
  • Contraceptive Patches
  • Vaginal Rings
  • Emergency Contraceptive Pills
  • Hormonal Implants
  • 6.6. Global Contraceptive Drugs And Devices Market, Sub-Segmentation Of Contraceptive Devices, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Male Condoms
  • Female Condoms
  • Intrauterine Devices (IUDs)
  • Diaphragms And Cervical Caps
  • Contraceptive Sponges
  • Sterilization Devices

7. Contraceptive Drugs And Devices Market Regional And Country Analysis

  • 7.1. Global Contraceptive Drugs And Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Contraceptive Drugs And Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Contraceptive Drugs And Devices Market

  • 8.1. Asia-Pacific Contraceptive Drugs And Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Contraceptive Drugs And Devices Market

  • 9.1. China Contraceptive Drugs And Devices Market Overview
  • 9.2. China Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Contraceptive Drugs And Devices Market

  • 10.1. India Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Contraceptive Drugs And Devices Market

  • 11.1. Japan Contraceptive Drugs And Devices Market Overview
  • 11.2. Japan Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Contraceptive Drugs And Devices Market

  • 12.1. Australia Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Contraceptive Drugs And Devices Market

  • 13.1. Indonesia Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Contraceptive Drugs And Devices Market

  • 14.1. South Korea Contraceptive Drugs And Devices Market Overview
  • 14.2. South Korea Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Contraceptive Drugs And Devices Market

  • 15.1. Western Europe Contraceptive Drugs And Devices Market Overview
  • 15.2. Western Europe Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Contraceptive Drugs And Devices Market

  • 16.1. UK Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Contraceptive Drugs And Devices Market

  • 17.1. Germany Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Contraceptive Drugs And Devices Market

  • 18.1. France Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Contraceptive Drugs And Devices Market

  • 19.1. Italy Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Contraceptive Drugs And Devices Market

  • 20.1. Spain Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Contraceptive Drugs And Devices Market

  • 21.1. Eastern Europe Contraceptive Drugs And Devices Market Overview
  • 21.2. Eastern Europe Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Contraceptive Drugs And Devices Market

  • 22.1. Russia Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Contraceptive Drugs And Devices Market

  • 23.1. North America Contraceptive Drugs And Devices Market Overview
  • 23.2. North America Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Contraceptive Drugs And Devices Market

  • 24.1. USA Contraceptive Drugs And Devices Market Overview
  • 24.2. USA Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Contraceptive Drugs And Devices Market

  • 25.1. Canada Contraceptive Drugs And Devices Market Overview
  • 25.2. Canada Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Contraceptive Drugs And Devices Market

  • 26.1. South America Contraceptive Drugs And Devices Market Overview
  • 26.2. South America Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Contraceptive Drugs And Devices Market

  • 27.1. Brazil Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Contraceptive Drugs And Devices Market

  • 28.1. Middle East Contraceptive Drugs And Devices Market Overview
  • 28.2. Middle East Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Contraceptive Drugs And Devices Market

  • 29.1. Africa Contraceptive Drugs And Devices Market Overview
  • 29.2. Africa Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Contraceptive Drugs And Devices Market Competitive Landscape And Company Profiles

  • 30.1. Contraceptive Drugs And Devices Market Competitive Landscape
  • 30.2. Contraceptive Drugs And Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Contraceptive Drugs And Devices Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceuticals Ltd
  • 31.2. Lupin Limited
  • 31.3. CooperSurgical Inc.
  • 31.4. Mithra Pharmaceuticals
  • 31.5. DKT International
  • 31.6. Fuji Latex Co Ltd
  • 31.7. Agile Therapeutics Inc.
  • 31.8. Cupid Limited
  • 31.9. Veru Inc.
  • 31.10. Eskag Pharma Pvt. Ltd.
  • 31.11. Biosante Pharmaceuticals Inc.
  • 31.12. HLL Lifecare Limited
  • 31.13. Afaxys Inc.
  • 31.14. The Female Health Company (FC2)
  • 31.15. Mayer Laboratories Inc.

32. Global Contraceptive Drugs And Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contraceptive Drugs And Devices Market

34. Recent Developments In The Contraceptive Drugs And Devices Market

35. Contraceptive Drugs And Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Contraceptive Drugs And Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Contraceptive Drugs And Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Contraceptive Drugs And Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제